Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

ClinicalTrials.gov ID: NCT07907783

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07907783. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 6:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Vehicle-Controlled, Phase 2 Study to Assess Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to evaluate safety and efficacy of PP405 in adult female participants with androgenetic alopecia

Study identification

NCT ID
NCT07907783
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pelage Pharmaceuticals, Inc.
Industry
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2026 (Estimated)
Primary completion
Sep 2027 (Estimated)
Completion
Mar 2028 (Estimated)
Last update posted
Nov 17, 2026

2026 – 2028

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913 Recruiting
DelRicht Research (Experience Dermatology) Atlanta Georgia 30329 Recruiting
Equity Medical, LLC New York New York 10023 Recruiting
DelRicht @Mt Pleasant Dermatology Mt. Pleasant South Carolina 29464 Recruiting
DelRicht Research @Harpeth Valley Dermatology Smyrna Tennessee 37167 Recruiting
Institution: Delricht Research @Lockhart Prosper Texas 75078 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07907783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.